The Division of Pediatric Endocrinology & Diabetes at Stanford
The work done by the division successfully combines the worlds of investigation, innovation, and clinical care to improve the diagnosis and treatment of endocrine disorders.
Division Founder's Legacy Honored
50 Years Ago in The Journal of Pediatrics is a brief reflection on the prolific and ground-breaking work of Raymond Hintz, MD, founder of the Division of Pediatric Endocrinology at Stanford School of Medicine and author of over 350 publications.
Maria Chang, MD (fellow), Darrell Wilson, MD (faculty), and David Maahs, MD, PhD (chief) recall Hintz' first publication, Familial Holoprosencephaly with Endocrine Dysgenesis (1968), in a December 26, 2017 Journal of Pediatrics column. Read more about Hintz at Stanford Medicine Scope.
It's a Match! - Holly Cooper & Walter Zegarra to Join Fellowship Program
We are thrilled to announce that on December 13, our fellowship training program matched two out of two positions. We look forward to welcoming Holly Cooper, MD from UCLA and Walter Zegarra, MD from University of Miami to our team beginning July 7th, 2018.
Fellow Welcome Lunch, July 2017
The division welcomed its newest fellows Ananta Addala, DO, MPH, and Jonathan Avila, MD with a lunch gathering during boot camp week. Welcome Ananta and Jonathan!
Fellow Graduation Party, June 2017
It's not easy saying goodbye - so it's a good thing we don't have to! The 2017 fellowship graduate, Hilary Seeley, MD, will be joining the division as clinical assistant professor of pediatrics. Congratulations, Hilary!
Fellows Shine at the ADA 77th Scientific Sessions, June 2017
Stanford faculty, trainees, and staff shared their scholarship at the American Diabetes Association’s (ADA) 77th Scientific Sessions in San Diego, June 9-14. See the more than twenty abstracts and poster sessions the Stanford community contributed to the conference.
Rayhan Lal, dual appointed adult and pediatric endocrinology fellow. Quantifying the Knowledge-Behavior Gap in Youth with Type 1 Diabetes (click for poster)
Laura Nally, pediatric endocrinology fellow. Reduced Hypoglycemia with Continuous Glucose Monitoring in Newly Diagnosed Youth with Type 1 Diabetes (click for poster)
Team Stanford Walks to Support Research for Type I Diabetes, Santa Clara 2017
The pediatric endocrinology division staff, faculty and fellows raised funds and showed their support for researching type 1 diabetes cures at Levi's Stadium on October 8, 2017 at a JDRF One Walk for a world without type 1 diabetes event.
We're Open! - New Packard Children's Hospital
Lucile Packard Children’s Hospital Stanford has created one of America’s most technologically advanced, family-friendly and environmentally sustainable hospitals for babies, children and pregnant women. The new hospital, opened its doors to patients on December 9, 2017 adding 521,000 square feet of building space and 149 patient beds to its facility.
The patient rooms are now private and feature a bathroom with shower, fold-out bed and privacy curtains so families have the option to stay in-room with their child. Computer workspace, child broadcast center, playground, kitchen and laundry help support families during their stay.
Animas shutting down US operations for insulin pumps
On October 5, 2017, Johnson and Johnson and Animas pump company have confirmed they will shut down U.S. operations, and exit the insulin pump market. They have selected Medtronic as their partner-of-choice, and are offering their patients to switch to Medtronic insulin pumps. Current Animas users can continue using their current pump, and will be able to get their Animas pump supplies (reservoirs and infusion sets) from the vendor.
New FIASP insulin approved for adults
On September 29, 2017, the FDA approved the new Novo Nordisk FIASP insulin for adults. This is a faster acting meal time insulin, that can be used instead of Humalog or Novolog. Check with your insurance company to determine whether or not this is a product on your formulary.
Freestyle Libre Flash CGM approved for adults
On September 27, 2017, the FDA approved the Freesyle Libre Flash Continuous Glucose Monitor (CGM) system in adults 18 years old and up. The sensor is factory calibrated, meaning it does not require any fingerstick calibrations. The sensor can be worn for up to 10 days, after a 12 hour warm up phase.
This multidisciplinary clinic provides medical services for gender nonconforming youths and their families in one central location. The expert members of the Gender Clinic team consists of providers from pediatric endocrinology, adolescent medicine, pediatric urology and social services, supporting each child’s or adolescent’s gender identity. All our providers are members of the World Professional Association for Transgender Health (WPATH).
The mission of the Stanford Diabetes Research Center is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness.
Join our mailing list
Subscribe to the pediatric endocrinology mailing list and receive emails regarding diabetes and the pediatric diabetes program here at Stanford.